How Automation Is Helping Healthcare Providers To Reduce Revenue Leakage

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Hospitals are losing millions of dollars annually as a result of denied claims, delayed reimbursements, coding errors and inefficient workflows. Revenue loss no longer only occurs when there are billing mistakes. It now impacts scheduling, eligibility checks, documentation correctness, payer communications, and follow-up processes as well. National health data shows that claim denial rates typically […]

The post How Automation Is Helping Healthcare Providers To Reduce Revenue Leakage appeared first on Medical News Bulletin.

Understanding Fertility Care: Treatment Options and Key Considerations

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

According to the information presented by the World Health Organization data, one out of six people reaching reproductive age is infertile. The same goes for the statistics of Australia, when one in six Australians is experiencing problems with infertility. The positive side of the modern era is the wide range of choices available, many of […]

The post Understanding Fertility Care: Treatment Options and Key Considerations appeared first on Medical News Bulletin.

How Much Is an Iron Infusion Near You? Understanding Treatment Costs

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Many people struggle with chronic fatigue, dizziness, headaches, or low energy for months before discovering that low iron levels may be the reason. In case your doctor has recommended treatment, one of the first questions that regularly comes up is the iron infusion price and whether or not it fits inside your budget. Understanding the […]

The post How Much Is an Iron Infusion Near You? Understanding Treatment Costs appeared first on Medical News Bulletin.

Top 10 Factors That Increase Your Risk of Food Allergies

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Scientists dug through more than 17,000 studies to figure out which kids are most likely to develop a food allergy before the age of six. No time to read the full meta-analysis by McMaster University, Canada allergists? No worries, we’ve gotcha. So what are the biggest risk factors for food allergies? Types of Risk Factor […]

The post Top 10 Factors That Increase Your Risk of Food Allergies appeared first on Medical News Bulletin.

Biceps tenodesis may be cost-effective vs. superior labrum repair

PHOENIX — Results from a Markov decision-analytic model showed biceps tenodesis offered both higher quality of life and lower costs than superior labrum anterior to posterior repair for overhead athletes with type 2 superior labrum tears.
“We found that biceps tenodesis is the preferred strategy from a cost-effectiveness standpoint in overhead athletes with type 2 [superior labrum anterior to posterior (SLAP)] tears over SLAP repair,” Matthew Frederickson, MD, a resident at the University of California, Davis, told Healio about results presented at the Arthroscopy Association of North America

Regimen ‘extremely encouraging’ in metastatic pancreatic cancer

A two-drug combination exhibited durable clinical benefit as second- or third-line treatment for pancreatic cancer, according to a topline data announcement released by one of the agent’s manufacturers.
A vast majority of patients with methylthioadenosine phosphorylase (MTAP)-deleted and RAS-mutant metastatic pancreatic ductal adenocarcinoma (PDAC) responded to treatment with vopimetostat (TNG-462, Tango Therapeutics) and daraxonrasib (RMC-6236, Revolution Medicines), results showed. Most remained progression free at 6 months.
The “extremely encouraging early results” support

Transient IOP increase observed after corneal cross-linking

Patients who underwent corneal cross-linking for keratoconus had a temporary but statistically significant increase in IOP in the months after the procedure, according to a study published in Journal of Glaucoma.
“The relationship between post-CXL biomechanical changes and tonometry in human eyes is not well understood, with studies reporting variable results in postoperative IOP measurements,” Wufan Zhao, of the department of ophthalmology at Duke University School of Medicine, and colleagues wrote. “Furthermore, postoperative topical corticosteroids, which are prescribed

Texas screwworm cases could be ‘canary in the coal mine’

Two more animal cases of the flesh-eating New World screwworm have been detected in Texas, bringing the total to four, the U.S. Department of Agriculture announced Monday.
The newest cases of New World screwworm (NWS) appeared in a calf in La Salle County and a dog in Andrews County, according to the USDA. Two cases were confirmed last week in calves in Zavala County, Texas.
NWS infestation occurs when a female fly lays eggs in the open wounds or orifices of mammals and the larvae hatch and feed on tissue. It usually affects livestock, but people can also be infested, leaving them vulnerable to

Insomnia linked to early-onset hormonal cancers in women

CHICAGO — Insomnia may play a significant role in the worldwide rise of early-onset malignancies, particularly among women.
Data presented at ASCO Annual Meeting showed that patients aged 50 years and younger diagnosed with primary insomnia had more than three times the likelihood of developing breast cancer, nearly double the risk for uterine cancer, and had 50% greater odds of ovarian cancer.
“It certainly was a surprise,” Vineet Polineni, DO, resident physician at Jefferson Health, told Healio. “Sleep disorders might be a clinically modifiable risk factor. It’s something to discuss with your

FDA expands Hympavzi approval to children with hemophilia A, B

The FDA has expanded approval for marstacimab-hncq, which can now be given as routine prophylaxis for all individuals aged 6 years and older with hemophilia A or B, with or without inhibitors, Pfizer announced in a press release.
Marstacimab-hncq (Hympavzi, Pfizer) is the first approved nonfactor, subcutaneous prophylaxis therapy for children with hemophilia B aged 6 to 11 years.
The agent, which is given once weekly and does not necessitate routine lab monitoring, previously received approval as the first antitissue factor pathway inhibitor in the U.S. for patients aged 12 years and older with